Immunological enhancement of primary tumor development and its prevention - PubMed (original) (raw)

Review

Immunological enhancement of primary tumor development and its prevention

H Schreiber et al. Semin Cancer Biol. 2000 Oct.

Abstract

While it has been known for decades that the growth of tumor transplants can be enhanced immunologically, the potential significance of these previous findings to the development of primary tumors and the mechanisms of tumor enhancement has remained obscure. This review will summarize recent experiments indicating that primary tumor development can be enhanced by active immunization. The evidence suggests that antibodies, B cells and CD4+ T cells can play a critical role in enhancing the development of primary, tumors, whereas endogenous interferon-gamma (IFNgamma) can counteract enhancement. Thus, we envision two possible functions of IFNgamma: (i) preventing B cell and antibody enhancement and (ii) counteracting tumor promotion independent of T and B cells.

PubMed Disclaimer

Similar articles

• Inflammatory cell infiltration of tumors: Jekyll or Hyde.
  Talmadge JE, Donkor M, Scholar E. Talmadge JE, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):373-400. doi: 10.1007/s10555-007-9072-0. Cancer Metastasis Rev. 2007. PMID: 17717638 Review.
• MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
  Bosch JJ, Thompson JA, Srivastava MK, Iheagwara UK, Murray TG, Lotem M, Ksander BR, Ostrand-Rosenberg S. Bosch JJ, et al. Cancer Res. 2007 May 1;67(9):4499-506. doi: 10.1158/0008-5472.CAN-06-3770. Cancer Res. 2007. PMID: 17483366
• CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
  Kennedy RC, Shearer MH, Watts AM, Bright RK. Kennedy RC, et al. Cancer Res. 2003 Mar 1;63(5):1040-5. Cancer Res. 2003. PMID: 12615720
• Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
  Nishikawa H, Kato T, Tawara I, Takemitsu T, Saito K, Wang L, Ikarashi Y, Wakasugi H, Nakayama T, Taniguchi M, Kuribayashi K, Old LJ, Shiku H. Nishikawa H, et al. Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9253-7. doi: 10.1073/pnas.0503852102. Epub 2005 Jun 16. Proc Natl Acad Sci U S A. 2005. PMID: 15961541 Free PMC article.
• Multiple roles for CD4+ T cells in anti-tumor immune responses.
  Kennedy R, Celis E. Kennedy R, et al. Immunol Rev. 2008 Apr;222:129-44. doi: 10.1111/j.1600-065X.2008.00616.x. Immunol Rev. 2008. PMID: 18363998 Review.

Cited by

• Harnessing B cells in immunotherapy.
  Cascalho M, Platt JL. Cascalho M, et al. Immunotherapy. 2016;8(3):237-9. doi: 10.2217/imt.15.119. Epub 2016 Feb 9. Immunotherapy. 2016. PMID: 26860221 Free PMC article. Review. No abstract available.
• Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.
  Thorn M, Point GR, Burga RA, Nguyen CT, Joseph Espat N, Katz SC. Thorn M, et al. J Leukoc Biol. 2014 Nov;96(5):883-94. doi: 10.1189/jlb.3A0114-012RR. Epub 2014 Aug 1. J Leukoc Biol. 2014. PMID: 25085111 Free PMC article.
• The roles of regulatory B cells in cancer.
  He Y, Qian H, Liu Y, Duan L, Li Y, Shi G. He Y, et al. J Immunol Res. 2014;2014:215471. doi: 10.1155/2014/215471. Epub 2014 Jun 2. J Immunol Res. 2014. PMID: 24991577 Free PMC article. Review.
• Evaluation of humoral immunity in oral cancer patients from a nigerian referral centre.
  Akinmoladun VI, Arinola OG, Elumelu-Kupoluyi T, Eriba LO. Akinmoladun VI, et al. J Maxillofac Oral Surg. 2013 Dec;12(4):410-3. doi: 10.1007/s12663-012-0440-0. Epub 2012 Sep 25. J Maxillofac Oral Surg. 2013. PMID: 24431879 Free PMC article.
• Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
  Kodar K, Izotova J, Klaamas K, Sergeyev B, Järvekülg L, Kurtenkov O. Kodar K, et al. World J Gastroenterol. 2013 Jun 21;19(23):3573-82. doi: 10.3748/wjg.v19.i23.3573. World J Gastroenterol. 2013. PMID: 23801858 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Research Materials

  • NCI CPTC Antibody Characterization Program